- Home
- ERAS vs PSBD Comparison
ERAS vs PSBD Comparison
Compare ERAS & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- PSBD
- Stock Information
- Founded
- ERAS 2018
- PSBD 2009
- Country
- ERAS United States
- PSBD United States
- Employees
- ERAS N/A
- PSBD N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- PSBD
- Sector
- ERAS Health Care
- PSBD
- Exchange
- ERAS Nasdaq
- PSBD Nasdaq
- Market Cap
- ERAS 432.6M
- PSBD 440.2M
- IPO Year
- ERAS 2021
- PSBD 2024
- Fundamental
- Price
- ERAS $1.16
- PSBD $12.81
- Analyst Decision
- ERAS Strong Buy
- PSBD Hold
- Analyst Count
- ERAS 6
- PSBD 3
- Target Price
- ERAS $4.83
- PSBD $16.17
- AVG Volume (30 Days)
- ERAS 2.3M
- PSBD 55.3K
- Earning Date
- ERAS 05-07-2025
- PSBD 05-07-2025
- Dividend Yield
- ERAS N/A
- PSBD 14.17%
- EPS Growth
- ERAS N/A
- PSBD N/A
- EPS
- ERAS N/A
- PSBD N/A
- Revenue
- ERAS N/A
- PSBD N/A
- Revenue This Year
- ERAS N/A
- PSBD N/A
- Revenue Next Year
- ERAS N/A
- PSBD N/A
- P/E Ratio
- ERAS N/A
- PSBD N/A
- Revenue Growth
- ERAS N/A
- PSBD N/A
- 52 Week Low
- ERAS $1.01
- PSBD $11.89
- 52 Week High
- ERAS $3.45
- PSBD $17.02
- Technical
- Relative Strength Index (RSI)
- ERAS 41.47
- PSBD 37.79
- Support Level
- ERAS $1.01
- PSBD $12.29
- Resistance Level
- ERAS $1.29
- PSBD $13.58
- Average True Range (ATR)
- ERAS 0.17
- PSBD 0.88
- MACD
- ERAS 0.00
- PSBD 0.02
- Stochastic Oscillator
- ERAS 31.25
- PSBD 37.25
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.